Genomics Medicine Ireland (GMI), the recently-acquired Irish subsidiary of WuXi NextCode, said today it has opened a research clinic in Dublin’s City Centre hub, with the goal of advancing precision medicine research and discovery...
Program designed for consumers who have taken a DTC genetic test, have a personal or family history of cancer and have unresolved questions.
The FDA approval is the third for a gene therapy, but is the first approval for a treatment using adeno associated viral vector delivery
Molecular diagnostics accounts for only a tenth of the in vitro diagnostics (IVD) market—but most of its hopes for future revenue growth.
From Guy's Hospital in London and the Sanger Centre during the Human Genome Project to one of the first to join early sequencing company Solexa and its subsequent acquisition by Illumina, David Bentley has seen clinical genomics come full circle.
Myriad Genetics will use myChoice HRD Plus to evaluate patients enrolled in an ongoing Phase III trial, in order to identify HRD cases
A new study shows PRSs developed by studying Europeans do a better job at predicting disease risk for people of European ancestry than for those of other ancestries
Partners will study immune disorders, antibiotic resistance by combining Microsoft's Azure cloud tech, APIs with Eagle's AI-based platform.
GlaxoSmithKline (GSK)’s recently announced $4.2 billion partnership to co-develop and co-commercialize Merck KGaA, Darmstadt’s cancer immunotherapy candidate M7824 was a reminder of just how much biopharma...
In 2013, much of the world was introduced to the burgeoning field of precision medicine when world-famous actress, Angelina Jolie, announced she had undergone...
The agency said it is unaware of data establishing that Inova’s tests helps patients or clinicians make appropriate treatment decisions for the listed drugs.
The genome-wide association study found 47 links between our genetic code and the quality, quantity, and timing of how we sleep, including ten linked with sleep duration and 26 with sleep quality.
The patent claims methods and compositions of using CRISPR/Cas9 to modify DNA and regulate gene activity in eukaryotic cells, including kits to carry out such work.
Myriad Genetics said today it has expanded its companion diagnostic collaboration with AstraZeneca and Merck & Co., which have agreed to use Myriad’s BRACAnalysis...
The gene, CCR4, was present in higher levels in patients with a good prognosis, even in those diagnosed with late stage colorectal cancer.